Sanders Morris Harris’s Opus Genetics IRD Stock Holding History

Sanders Morris Harris’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,000	Closed	-$54.6K	–	289
2026 Q1	$54.6K	Buy	+12,000	New	+$41.5K	0.01%	286

Other funds holding IRD

FCCM

First City Capital Management Savannah, Georgia $206M AUM 26.13% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sanders Morris Harris's IRD Position: Q2 2026 in Review

Sanders Morris Harris sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 12,000 shares — an estimated $54.6K sold.

Sanders Morris Harris first reported a position in IRD in Q1 2026 and held it in 1 quarter. The position peaked at $54.6K in Q1 2026. 2 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

Sanders Morris Harris reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
Sanders Morris Harris sold 12,000 Opus Genetics shares in Q2 2026, an estimated $54.6K.
Sanders Morris Harris first reported a position in Opus Genetics in Q1 2026 and held it in 1 quarter.
Sanders Morris Harris's Opus Genetics position peaked at $54.6K in Q1 2026.
2 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.